| 摘要 |
The present invention relates to compositions and methods for treatment and/or prevention of a cardiovascular disease. In one embodiment, the compositions and methods of the invention relate to continuous administration of a GLP-1 or a metabolite thereof for the treatment and/or prevention of a cardiovascular disease. Glucagon -like peptide- 1 ( G LP -1 ) is a gastrointestinal hormone (an incretion) that stimulates insulin release. |
